Skip to main content
lexblog.com/lib/78PWV01Gviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA CBD Hearing Leaves Questions Unanswered",
    "url": "https://www.lexblog.com/2019/06/04/fda-cbd-hearing-leaves-questions-unanswered/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-78PWV01G",
        "url": "https://www.lexblog.com/lib/78PWV01G/"
    },
    "datePublished": "2019-06-04T09:19:59-04:00",
    "dateModified": "2019-06-04T13:32:55-04:00",
    "author": {
        "@type": "Person",
        "name": "Snehal Trivedi"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Foley Hoag LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Cannabis & the Law",
    "about": "Cannabis",
    "sourceUrl": "http://www.cannabisandthelaw.com/2019/06/04/fda-cbd-hearing-leaves-questions-unanswered/",
    "sourceStability": "may-move"
}